Represented FluoroPharma Medical, Inc., a company engaged in the development of medical diagnostic imaging technology, as issuer’s counsel in a $4 million private placement of convertible preferred stock and other private placements of securities.
It looks like we may have content for your preferred language. Would you like to view this page in English?
